Citadel Advisors
IMGN

Citadel Advisors’s Immunogen Inc IMGN Stock Holding History

Citadel Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-288,200
Closed -$8.55M – 15810
2023
Q4 		$8.55M Buy
288,200
+21,700
+8% +$432K ﹤0.01% 3062
2023
Q3 		$4.23M Buy
266,500
+42,500
+19% +$707K ﹤0.01% 3931
2023
Q2 		$4.23M Buy
224,000
+56,900
+34% +$672K ﹤0.01% 3913
2023
Q1 		$642K Buy
167,100
+126,800
+315% +$540K ﹤0.01% 7782
2022
Q4 		$200K Buy
40,300
+25,000
+163% +$136K ﹤0.01% 10142
2022
Q3 		$73K Sell
15,300
-6,600
-30% -$34.8K ﹤0.01% 11349
2022
Q2 		$99K Sell
21,900
-44,300
-67% -$192K ﹤0.01% 11424
2022
Q1 		$315K Buy
66,200
+39,700
+150% +$220K ﹤0.01% 10489
2021
Q4 		$197K Sell
26,500
-12,500
-32% -$77.7K ﹤0.01% 11877
2021
Q3 		$221K Sell
39,000
-26,000
-40% -$150K ﹤0.01% 11776
2021
Q2 		$428K Buy
65,000
+23,800
+58% +$166K ﹤0.01% 10405
2021
Q1 		$334K Buy
41,200
+15,300
+59% +$125K ﹤0.01% 10591
2020
Q4 		$167K Sell
25,900
-9,700
-27% -$56.6K ﹤0.01% 9876
2020
Q3 		$128K Sell
35,600
-9,600
-21% -$38.8K ﹤0.01% 9115
2020
Q2 		$208K Buy
45,200
+10,400
+30% +$44.2K ﹤0.01% 8477
2020
Q1 		$119K Buy
34,800
+900
+3% +$3.94K ﹤0.01% 8508
2019
Q4 		$173K Buy
33,900
+12,000
+55% +$40.7K ﹤0.01% 8286
2019
Q3 		$53K Sell
21,900
-600
-3% -$1.59K ﹤0.01% 8685
2019
Q2 		$49K Sell
22,500
-75,500
-77% -$179K ﹤0.01% 8737
2019
Q1 		$266K Buy
98,000
+33,500
+52% +$145K ﹤0.01% 7791
2018
Q4 		$310K Buy
64,500
+3,300
+5% +$20K ﹤0.01% 7202
2018
Q3 		$580K Buy
61,200
+3,000
+5% +$28.8K ﹤0.01% 6462
2018
Q2 		$566K Buy
58,200
+22,000
+61% +$232K ﹤0.01% 6161
2018
Q1 		$381K Buy
36,200
+23,600
+187% +$233K ﹤0.01% 6349
2017
Q4 		$81K Sell
12,600
-14,700
-54% -$90.7K ﹤0.01% 7499
2017
Q3 		$209K Buy
27,300
+2,100
+8% +$14K ﹤0.01% 6634
2017
Q2 		$179K Buy
25,200
+500
+2% +$2.29K ﹤0.01% 6635
2017
Q1 		$96K Sell
24,700
-7,800
-24% -$22.8K ﹤0.01% 6874
2016
Q4 		$66K Buy
32,500
+3,300
+11% +$6.63K ﹤0.01% 6799
2016
Q3 		$78K Buy
29,200
+15,600
+115% +$45.4K ﹤0.01% 6730
2016
Q2 		$42K Buy
13,600
+2,700
+25% +$16.9K ﹤0.01% 6451
2016
Q1 		$93K Buy
10,900
+8,400
+336% +$71.1K ﹤0.01% 6059
2015
Q4 		$34K Sell
2,500
-7,300
-74% -$89.9K ﹤0.01% 7589
2015
Q3 		$94K Sell
9,800
-6,800
-41% -$99.4K ﹤0.01% 7017
2015
Q2 		$239K Sell
16,600
-3,600
-18% -$39.5K ﹤0.01% 6078
2015
Q1 		$181K Sell
20,200
-22,700
-53% -$164K ﹤0.01% 6297
2014
Q4 		$262K Buy
42,900
+22,300
+108% +$204K ﹤0.01% 5631
2014
Q3 		$218K Sell
20,600
-6,100
-23% -$69K ﹤0.01% 5641
2014
Q2 		$316K Buy
26,700
+11,400
+75% +$143K ﹤0.01% 5013
2014
Q1 		$228K Sell
15,300
-25,700
-63% -$405K ﹤0.01% 5382
2013
Q4 		$601K Buy
41,000
+10,800
+36% +$166K ﹤0.01% 3798
2013
Q3 		$514K Buy
30,200
+11,600
+62% +$204K ﹤0.01% 3788
2013
Q2 		$309K Buy
+18,600
New +$301K ﹤0.01% 4278

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's IMGN Position: Q1 2024 in Review

Citadel Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 795,458 shares — an estimated $23.6M sold.

Citadel Advisors first reported a position in IMGN in Q2 2013 and held it in 38 quarters. The position peaked at $23.6M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Citadel Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 795,458 Immunogen Inc shares in Q1 2024, an estimated $23.6M.
  • Citadel Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 38 quarters.
  • Citadel Advisors's Immunogen Inc position peaked at $23.6M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.